259 related articles for article (PubMed ID: 33825443)
1. Synergistic Association between Plasma Aβ
Chiu MJ; Yang SY; Chen TF; Lin CH; Yang FC; Chen WP; Zetterberg H; Blennow K
ACS Chem Neurosci; 2021 Apr; 12(8):1376-1383. PubMed ID: 33825443
[TBL] [Abstract][Full Text] [Related]
2. Relevance of plasma biomarkers to pathologies in Alzheimer's disease, Parkinson's disease and frontotemporal dementia.
Chiu PY; Yang FC; Chiu MJ; Lin WC; Lu CH; Yang SY
Sci Rep; 2022 Oct; 12(1):17919. PubMed ID: 36289355
[TBL] [Abstract][Full Text] [Related]
3. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.
Skillbäck T; Farahmand BY; Rosén C; Mattsson N; Nägga K; Kilander L; Religa D; Wimo A; Winblad B; Schott JM; Blennow K; Eriksdotter M; Zetterberg H
Brain; 2015 Sep; 138(Pt 9):2716-31. PubMed ID: 26133663
[TBL] [Abstract][Full Text] [Related]
5. Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer's disease.
Xiao Z; Wu X; Wu W; Yi J; Liang X; Ding S; Zheng L; Luo J; Gu H; Zhao Q; Xu H; Ding D
Alzheimers Res Ther; 2021 Jul; 13(1):123. PubMed ID: 34225797
[TBL] [Abstract][Full Text] [Related]
6. Blood Neurofilament Light Chain in Different Types of Dementia.
Gu L; Shu H; Wang Y; Wang P
Curr Alzheimer Res; 2023; 20(3):149-160. PubMed ID: 37264656
[TBL] [Abstract][Full Text] [Related]
7. Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer's disease and frontotemporal lobar degeneration.
Benussi A; Cantoni V; Rivolta J; Archetti S; Micheli A; Ashton N; Zetterberg H; Blennow K; Borroni B
Alzheimers Res Ther; 2022 Oct; 14(1):155. PubMed ID: 36229847
[TBL] [Abstract][Full Text] [Related]
8. Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study.
Fiandaca MS; Kapogiannis D; Mapstone M; Boxer A; Eitan E; Schwartz JB; Abner EL; Petersen RC; Federoff HJ; Miller BL; Goetzl EJ
Alzheimers Dement; 2015 Jun; 11(6):600-7.e1. PubMed ID: 25130657
[TBL] [Abstract][Full Text] [Related]
9. Performance of aβ1-40, aβ1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment.
Parnetti L; Chiasserini D; Eusebi P; Giannandrea D; Bellomo G; De Carlo C; Padiglioni C; Mastrocola S; Lisetti V; Calabresi P
J Alzheimers Dis; 2012; 29(1):229-38. PubMed ID: 22232006
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.
Paterson RW; Slattery CF; Poole T; Nicholas JM; Magdalinou NK; Toombs J; Chapman MD; Lunn MP; Heslegrave AJ; Foiani MS; Weston PSJ; Keshavan A; Rohrer JD; Rossor MN; Warren JD; Mummery CJ; Blennow K; Fox NC; Zetterberg H; Schott JM
Alzheimers Res Ther; 2018 Mar; 10(1):32. PubMed ID: 29558979
[TBL] [Abstract][Full Text] [Related]
11. Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.
Kang JH; Irwin DJ; Chen-Plotkin AS; Siderowf A; Caspell C; Coffey CS; Waligórska T; Taylor P; Pan S; Frasier M; Marek K; Kieburtz K; Jennings D; Simuni T; Tanner CM; Singleton A; Toga AW; Chowdhury S; Mollenhauer B; Trojanowski JQ; Shaw LM;
JAMA Neurol; 2013 Oct; 70(10):1277-87. PubMed ID: 23979011
[TBL] [Abstract][Full Text] [Related]
12. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicle biomarkers for cognitive impairment in Parkinson's disease.
Blommer J; Pitcher T; Mustapic M; Eren E; Yao PJ; Vreones MP; Pucha KA; Dalrymple-Alford J; Shoorangiz R; Meissner WG; Anderson T; Kapogiannis D
Brain; 2023 Jan; 146(1):195-208. PubMed ID: 35833836
[TBL] [Abstract][Full Text] [Related]
14. Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression.
Clark C; Lewczuk P; Kornhuber J; Richiardi J; Maréchal B; Karikari TK; Blennow K; Zetterberg H; Popp J
Alzheimers Res Ther; 2021 Mar; 13(1):65. PubMed ID: 33766131
[TBL] [Abstract][Full Text] [Related]
15. A Comparison of Cerebrospinal Fluid Beta-Amyloid and Tau in Idiopathic Normal Pressure Hydrocephalus and Neurodegenerative Dementias.
Said HM; Kaya D; Yavuz I; Dost FS; Altun ZS; Isik AT
Clin Interv Aging; 2022; 17():467-477. PubMed ID: 35431542
[TBL] [Abstract][Full Text] [Related]
16. The free plasma amyloid Aβ
Schraen-Maschke S; Duhamel A; Vidal JS; Ramdane N; Vaudran L; Dussart C; Buée L; Sablonnière B; Delaby C; Allinquant B; Gabelle A; Bombois S; Lehmann S; Hanon O;
Neurobiol Dis; 2024 Apr; 193():106459. PubMed ID: 38423192
[TBL] [Abstract][Full Text] [Related]
17. Social Networks and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
Ma YH; Wang YY; Tan L; Xu W; Shen XN; Wang HF; Hou XH; Cao XP; Bi YL; Dong Q; Yang JL; Yu JT
J Alzheimers Dis; 2021; 81(1):263-272. PubMed ID: 33749650
[TBL] [Abstract][Full Text] [Related]
18. Analysis of combined CSF biomarkers in AD diagnosis.
De Riva V; Galloni E; Marcon M; Di Dionisio L; Deluca C; Meligrana L; Bolner A; Perini F
Clin Lab; 2014; 60(4):629-34. PubMed ID: 24779297
[TBL] [Abstract][Full Text] [Related]
19. Plasma extracellular vesicles tau and β-amyloid as biomarkers of cognitive dysfunction of Parkinson's disease.
Chung CC; Chan L; Chen JH; Bamodu OA; Chiu HW; Hong CT
FASEB J; 2021 Oct; 35(10):e21895. PubMed ID: 34478572
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid N-224 tau helps discriminate Alzheimer's disease from subjective cognitive decline and other dementias.
Cicognola C; Hansson O; Scheltens P; Kvartsberg H; Zetterberg H; Teunissen CE; Blennow K
Alzheimers Res Ther; 2021 Feb; 13(1):38. PubMed ID: 33557920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
